- €12.72bn
- €17.58bn
- €3.54bn
Brief: Sartorius Opens Competence Center In Freiburg
Bio‑Rad Laboratories jumps after report Elliott builds stake
Sartorius shares rise after report of Elliott investment
Elliott builds big stake in life-science tools supplier Bio-Rad Labs, WSJ reports (updated)
Brief: Activist Elliott Investment Management Has Built A Sizable Stake In Bio-Rad Laboratories- WSJ
Sartorius falls after report questions Polyplus deal
Brief: Sartorius Completes Placement Of Bond With A Volume Of EUR 500 Mln
Bio-Rad falls after Q1 net loss, cuts 2026 revenue outlook
Sartorius rises after Berenberg upgrade
Sartorius down premarket after margin disappoints
Germany's Sartorius Q1 revenue rises 7.5% in constant currencies
Brief: Sartorius Q1 Adjusted EBITDA Margin 29.7%
GS upgrades Sartorius Stedim to 'buy' after share price pullback
Brief: Sartorius Shareholders Approve Dividend Of EUR 0.74 Per Preference Share, EUR 0.73 Per Ordinary Share
Sartorius, Stedim Biotech shares rise on 'positive' mid-term guidance
Brief: Sartorius AG - Mid-Term Outlook: Sales Growth At 8 To 11 Percent Per Year
Brief: Sartorius Sharpens Strategy With Biopharma Focus, Sets New Midterm Growth Targets
Europe Research Roundup: Danone, Emeis, Sandoz Group
Brief: Sartorius Proposes Dividend Of 0.74 Euros Per Preference Share